AxioMed introduced its lateral total disc replacement, for which first surgery completion is expected by year-end in Jamaica.
The company is expanding its executive team to oversee commercialization of the disc ex-U.S., while pursuing a 2018 FDA Premarket Approval for the device.
AxioMed recently closed a first investment round and opened a second $10.0MM round to support ex-U.S. commercialization and U.S. cervical Investigational Device Exemption study.
AxioMed’s Lateral Approach to TDR, courtesy of AxioMed LLC
AxioMed introduced its lateral total disc replacement, for which first surgery completion is expected by year-end in Jamaica.
The company is expanding its executive team to oversee commercialization of the disc ex-U.S., while pursuing a 2018 FDA Premarket Approval for the device.
AxioMed recently closed a first investment round and opened a...
AxioMed introduced its lateral total disc replacement, for which first surgery completion is expected by year-end in Jamaica.
The company is expanding its executive team to oversee commercialization of the disc ex-U.S., while pursuing a 2018 FDA Premarket Approval for the device.
AxioMed recently closed a first investment round and opened a second $10.0MM round to support ex-U.S. commercialization and U.S. cervical Investigational Device Exemption study.
Copy to clipboard 
